Peripheral neuropathy in XDR-TB patients on second line anti-tubercular therapy Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Incidence of peripheral polyneuropathy among patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 539s Year: 2003
Incidence of hearing impairment after intra muscular streptomycin of pediatric patients during directly observed treatment short-course using quadruple regimen at a tertiary hospital Source: Eur Respir J 2003; 22: Suppl. 45, 519s Year: 2003
Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Efficacy of standard 1st category regimen of chemotherapy in patients with smear positive destructive pulmonary tuberculosis in Chernigovskaya oblast, Ukraine Source: Eur Respir J 2006; 28: Suppl. 50, 8s Year: 2006
Pegfilgrastim drastically lowered risk of febrile neutropenia in Japanese patients with thoracic malignancy receiving chemotherapy - a retrospective single institutional study Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018
Efficacy of standard 1st category regimen of chemotherapy in patients with smear positive destructive pulmonary tuberculosis in Chernovetskaya Oblast, Ukraine Source: Eur Respir J 2006; 28: Suppl. 50, 379s Year: 2006
A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate? Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Prevalence of small fiber neuropathy in patients with sarcoidosis in an outpatient setting. Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021
Adverse effects of treatment in HIV-associated tuberculosis patients in Iran Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011
Treatment outcomes under early correction of chemotherapy in adolescents with advanced pulmonary TB Source: Annual Congress 2007 - Clinical tuberculosis Year: 2007
Incidence of tuberculosis among anti-TNF users in patients with previous history of tuberculosis Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013
Comparison of treatment of TB lymphadenitis with daily vs. intermittent chemotherapy Source: Annual Congress 2011 - Pulmonary and extrapulmonary tuberculosis Year: 2011
Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis in an endemic area Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013
Recurrent TB in Ireland is predominantly due to relapsed infection and is frequently associated with poor compliance with therapy Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
Secondary drug resistance during an intravenous intermittent chemotherapy in newly cases TB Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011
Clinical efficacy of new anti-TB drug ²tubelon² during complex chemotherapy in patients with first-time diagnosed destuctive pulmonary TB Source: Eur Respir J 2006; 28: Suppl. 50, 8s Year: 2006
Preventive chemotherapy effectiveness in children and adolescents, contacting TB patients with DR TB strains Source: Eur Respir J 2006; 28: Suppl. 50, 536s Year: 2006
Predictors of treatment failure among pulmonary tuberculosis patients in Pakistan Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
Impact of diabetes mellitus on clinical parameters and treatment outcomes of diagnosed pulmonary tuberculosis patients Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014